ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 862

Ten-Year Incidence of Self-Reported Nonvertebral Fractures in 9,720 Japanese Patients With Rheumatoid Arthritis: A Prospective Observational Cohort Study

Kensuke Ochi1, Takefumi Furuya1, Eisuke Inoue2, Katsunori Ikari1, Atsuo Taniguchi2, Hisashi Yamanaka1 and Shigeki Momohara2, 1Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 2Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Disease Activity, fractures, functional status, Osteoporosis and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoporosis and Metabolic Bone Disease: Clinical Aspects and Pathogenesis

Session Type: Abstract Submissions (ACR)

Ten-Year Incidence of Self-reported Nonvertebral Fractures in 9,720 Japanese Patients with Rheumatoid Arthritis: A Prospective Observational Cohort Study

Background/Purpose: Although rheumatoid arthritis (RA) is a risk factor for osteoporosis and fracture, few studies have described the correlation between disease activity of RA and incidence of fracture in patients with RA.  We previously reported that disease activity in our Institute of Rheumatology Rheumatoid Arthritis (IORRA) cohort improved significantly from 2001 to 2010; however, the change in the incidence of fractures in this period is unknown.  This study aimed to investigate the change in the incidence of nonvertebral fractures between 2001 and 2010.

Methods: The IORRA is a prospective observational cohort study of Japanese RA patients at the Institute of Rheumatology, Tokyo Women’s Medical University.  A total of 9,720 patients (82% female; mean age, 56 years) with RA were enrolled in the IORRA cohort study from 2000 to 2010.  Clinical parameters, including physician’s assessment, patient’s assessment, and laboratory data, were collected biannually in April and October.  All participants self-reported the occurrence of a nonvertebral fracture within the previous 6 months and the fracture sites.  Statistical analysis was performed using the ƒÔ2 test with a confidence interval of 95%.

Results: From 2001 to 2010, the percentage of patients with DAS28 remission increased from 7.8% to 39.7%, the mean score on the Japanese version of the health assessment questionnaire decreased from 0.82 to 0.65, prednisolone intake decreased from 51.4% (mean, 4.7 mg/day) to 41.3% (mean, 4.1 mg/day), and bisphosphonate intake increased from 5.0% to 23.4%.  The incidence of nonvertebral fracture was 1.19% in 2001 and 1.79% in 2010, with no apparent change (mean, 1.78% [0.23%]; Figure 1).  The incidence of fracture increased dramatically after the age of 45 years in women, while the increase was linear in men.  The mean age of fracture (year) and the mean incidence of fracture (%) were 61.8 (12.7) and 0.36 (0.05) in the ribs, 65.9 (11.1) and 0.07 (0.03) in the pelvis, 66.8 (10.4) and 0.11 (0.04) in the shoulder, 67.4 (10.4) and 0.12 (0.04) in the wrist, 68.4 (9.4) and 0.18 (0.06) in the hip, and 62.5 (10.6) and 0.13 (0.04) in the ankle, respectively.  Overall incidence of nonvertebral fracture was significantly higher in the autumn/winter than in the spring/summer (p = 0.02).

Conclusion: Despite the improvement in disease activity and functional disability, the incidence of nonvertebral fracture appears to show no apparent change between 2001 and 2010 in our patients with RA.


Disclosure:

K. Ochi,
None;

T. Furuya,
None;

E. Inoue,
None;

K. Ikari,

Pfizer Inc,

2,

Takeda ,

2,

Asahikasei,

8,

AbbVie,

8,

Astellas,

8,

Eisai,

8,

Kaken,

8,

Mitsubishi Tanabe,

8,

Taisho Toyama,

8;

A. Taniguchi,
None;

H. Yamanaka,

Chugai Pharmaceutical Co.,Ltd., Astellas Pharma Inc., Wyeth K.K., Daiichi Sankyo Co.,Ltd., Banyu Pharmaceutical Co.,Ltd., Mitsubishi Tanabe Pharma Corporation, Abbott Japan Co.,Ltd., Eisai Co.,Ltd., Santen Pharmaceutical Co.,Ltd., Taishotoyama Pharmaceuti,

2,

Abbott, Eisai Co.,Ltd., Takeda Pharmaceutical Company Limited, Mitsubishi Tanabe Pharma Corporation, Janssen Pharmaceutical K.K., Hoffmann-La Roche, Chugai Pharmaceutical Co.,Ltd. ,

5;

S. Momohara,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ten-year-incidence-of-self-reported-nonvertebral-fractures-in-9720-japanese-patients-with-rheumatoid-arthritis-a-prospective-observational-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology